Quick Takeaways
- Christopher J. Coughlin has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,984,784.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Christopher J. Coughlin and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CNC | CENTENE CORP | Director | $2,205,979 | 31 Mar 2026 | ||
| PBH | Prestige Consumer Healthcare Inc. | Director | $778,805 | 02 Aug 2022 | ||
| KRTX | Karuna Therapeutics, Inc. | Director | $0 | 18 Mar 2024 | ||
| ALXN | ALEXION PHARMACEUTICALS, INC. | Director | 21 Jul 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|